Peginterferon

Study	Exclusion reasons	Rmk	Reference
de Niet, 2017	case report or case series	'Two (4%) serious adverse events were reported in the pegIFN plus adefovir group (admission to hospital for alcohol related pancreatitis [week 6; n=1] and pregnancy'
Roberts, 2010	case report or case series		Roberts Birth Defects Res. Part A Clin. Mol. Teratol. 2010; 88:551-9 10.1002/bdra.20682
Lu, 2015	not relevant exposure	Chronic hepatitis B pregnant women were treated with Telbivudine during the third trimester of their pregnancy. After childbirth, the patients were either switched to CPIA treatment or stopped Telbivudine treatment...	Lu Liver Int. 2015; 35:1692-9 10.1111/liv.12753
Birgegard, 2018	Studies without separate analysis of the considered drug/class from other drugs/class	Fifty-four pregnancies (40 patients) occurred. Nine patients had no therapy, 24 had IFN (one patient had HC IFN), 10 had anagrelide, eight had A-A, and three were receiving anticoagulant without CRT at the time that pregnancy was reported.	Birgegard Haematologica 2018; 103:51-60 10.3324/haematol.2017.174672